Genzyme boss counters Sanofi-Aventis hostile bid
(AFP)
Unusual Little Blurbs
AFP - The head of US biotechnology group Genzyme on Friday tried to deflect a 18.5 billion dollar hostile takeover bid by French pharmaceutical giant Sanofi-Aventis, saying it sharply undervalued the firm.